DIAGNOSTIC VALUE OF PROLIFERATION MARKERS IN DETERMINATION OF THE SEVERITY OF PRECANCEROUS CERVICAL CONDITIONS

Authors

  • Е. P. Gnatko Національний медичний університет імені О. О. Богомольця, м. Київ
  • N. G. Skuriatina Національний медичний університет імені О. О. Богомольця, м. Київ
  • T. A. Berezhna ККЛ ЗТ № 2 Філія «ЦОЗ» ПАТ «Укрзалізниця», м. Київ

DOI:

https://doi.org/10.11603/24116-4944.2018.1.8736

Keywords:

cervix, proliferation markers, colposcopy, cytology.

Abstract

The aim of the study – to evaluate the diagnostic value of P16/Ki-67 proliferation markers in determination of oncogenic transformation at various severity of cervical dysplasia.

Materials and Methods. 82 women aged 24–47 years with cervical dysplasia of varying severity were examined. In addition to general clinical examination, colposcopic, cytological, microbiological and histological studies were performed. P16/Ki-67 proliferation markers were examined by immunocytochemical method.

Results and Discussion. According to cytological examination CIN I was diagnosed in 59 (72.0 %), CIN II in 16 (19.5 %), CIN III in 7 (8.5 %) women. Atypical colposcopic pattern was revealed in all patients. According to the results of HPV test, the most common HPV type 16 (25.4 % to 100 %), common HPV types 18.31 and 33 at CIN of varying severity were observed. Positive P16/Ki-67 markers were found in 10 (16.9 %) women with CIN I, 9 (56.3 %) with CIN II and 6 (85.7 %) with CIN IІI. Comparisonof the cytological and histological results in patients with positive P16/Ki-67 markers showed that among 10 women with CIN I, 4 (40.0 %) had CIN II and 5 (50.0 %) CIN III; among 9 patients with CIN II, 6 (66.7 %) had CIN III; in 3 (50.0 %) women with CINIII their diagnosis was confirmed, Ca in situ in 1 (16.7 %) and invasive cancer in 2 (33.3 %) were diagnosed. Thus, the cytological method combined with HPV test did not allow to diagnose severe intraepithelial cervical lesions in 17.1 %.

Conclusions. The comprehensive examination with cytology and HPV test should be supplemented with determination of specific proliferation markers. Thus, an integrative stage of changes in the virus that has an oncogenic potential can be established and the severity of dysplastic changes in the cervical epithelium can be verified. This is important for early diagnosis of cervical cancer.

References

Baryaeva, O.E. (Ed.). (2012). Fonovye i predrakovye zabolevaniya sheyki matki: uchebnoye posobie [Background and precancerous cervical diseases]. Irkutsk: IGMU [in Russian].

Kondratiuk, V.K., Horban, N.Ye., & Narolska, A.I (2014). Dysplasiia epiteliia shyiky matky: etiolohiia, diahnostyka, likuvannia [Cervical epithelial dysplasia: etiology, diagnostics, treatment]. Reproduktyvna endokrynolohiia – Reproductive Endocrinology, 3(17), 105-109 [in Ukrainian].

Kovanda, A., Juvan, U., & Sterbenc, A. (2009). Pre-vaccination distribution of human papillomavirus (HPV) geno-types in women with cervical intraepithelial neoplasia grade 3 (CIN 3) lesions in Slovenia. Acta Dermatovenerol. Alp. Panonica Adriat., 18 (2), 47-52.

Korolenkova, L.I. (2010). Molekuliarno-biologicheskie markery proliferatsii i apoptoza kak faktory proliferatsii tservikalnykh intraepitelialnykh neoplazii sheyki matki [Molecular-biological markers of proliferation and apoptosis as factors of proliferation of intraepithelial cervical neoplasia]. Rossiyskiy bioterapevticheskiy zhurnal – Russian Bio-therapeutic Journal, 9 (4), 11-16 [in Russian].

Prilepskaya, V.N., Bayramova, G.R., Kogan, Е.А., & Chernova, V.F. (2015). Novye vozmozhnosti ranney diagnostiki i profilaktiki VPCh-assotsiirovannykh porazheniy sheyki matki [New opportunities for early diagnosis and prevention of HPV-associated cervical lesions]. Meditsinskiy sovet. Ginekologiya – Medical Council. Gynecology, 72-76 [in Russian].

Zhylka, N.Ya., & Zaikova, T.V. (2012) Epidemiolohiia raku shyiky matky v Ukraini [Epidemiology of cervical cancer in Ukraine]. Ukraina. Zdorovia natsii – Ukraine. Nation Health, 4 (24), 40-47 [in Ukrainian].

Giannella, L., Fodero, С., Boselli, F. (2015). Age-related changes in the diagnostic assessment of women with severe cervical lesions. Climacteric, 18, 4, 617-623.

Grigore, M., Teleman, S., & Ungureanu, D. (2013). Molecular markers in cervical screening – a promise for the future [Utilitatea markerilor moleculari în screening-ul cancerului de col uterin]. Romanian Review of Laboratory Medicine, 21, 2/4, 231-239.

Bergeron, С., Ordi, J., Schmidt, D., & Bergeron, C. (2010). Conjunctive p16 (INK4a) testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia. Am. J. Clin. Pathol, 133 (3), 395-406.

Karpishchenko, А.I. (Ed.). (2001). Meditsinskaya laboratornaya diagnostika (programmy i algoritmy [Medical laboratory diagnostics (programs and algorithms)]. Saint-Petersburg: Intermedika [in Russian].

Published

2018-05-03

How to Cite

Gnatko Е. P., Skuriatina, N. G., & Berezhna, T. A. (2018). DIAGNOSTIC VALUE OF PROLIFERATION MARKERS IN DETERMINATION OF THE SEVERITY OF PRECANCEROUS CERVICAL CONDITIONS. Actual Problems of Pediatrics, Obstetrics and Gynecology, (1). https://doi.org/10.11603/24116-4944.2018.1.8736

Issue

Section

OBSTETRICS AND GYNECOLOGY